Research Center Aims to Expand Opportunities

The hallway on the second floor at 823 Mulvane in Topeka looks unassuming enough, but behind one of the doors lies the future of medicine.

"Cutting edge" is how Mary Martell describes the physicians involved with the Cotton-O'Neil Clinical Research Center.

Martell is director of the new center. Already, it's tracking some twenty clinical trials Cotton-O'Neil physicians are involved in, everything from diabetes to behavior. The Research Center not only gives doctors an alternative location for seeing study patients, for the first time, it gives them a dedicated central support staff.

Martell says the Center will recruit new trials, provide administrative help for physicians, like regulatory paperwork, and provide study staff. In the past, she says, doctors who wanted to participate in a trial had to have their own office staff do the extra work.

Dr. Allen Kossoy knows how much work trials involve. He's involved in childhood asthma studies. Dr. Kossoy says having trials available in Topeka is a big plus for patients. He said it gives them access to new medications they may otherwise not be able to try.

He's excited about the possibilities the Research Center holds for attracting even more trials.

"This is going to put us at the forefront of a lot of new therapies," he said.

Study participants often get free medicines and medical checkups. For information, call (785) 368-0744, or, for oncology research information, (785) 354-0540.

The Cotton-O'Neil Clinical Research Center is currently recruiting patients for clinical trials dealing with the following conditions:
Pediatric Asthma
Pediatric Rhinitis
Functional Dyspepsia
Ulcerative Colitis
Behavior Health
Overactive Bladder
Type I Diabetes
Type II Diabetes
Hypertension (High Blood Pressure)
Hypercholesterolemia (High Cholesterol)

631 SW Commerce Pl. Topeka, Kansas 66615 phone: 785-272-6397 fax: 785-272-1363 email:
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 1332312 -
Gray Television, Inc.